lipoxin a4 has been researched along with Sepsis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, LL; Jiang, WW; Shen, DL; Wu, M; Zhao, T | 1 |
| da Silva, RF; da-Palma-Cruz, M; de Oliveira, APL; Grabulosa, CC; Lino-Dos-Santos-Franco, A; Monteiro, D; Rehim, HMMA | 1 |
| Gao, LL; Lin, XY; Shen, DL; Wu, M; Zhao, T | 1 |
| Banerjee, P; Mian, K; Rodriguez, A; Spur, B; Stein, TP; Temmermand, D; Walker, JA; Wu, B; Yin, K | 1 |
| Hsu, HC; Shih, CH; Tsai, WH; Yu, YB | 1 |
| Assreuy, J; Horewicz, V; Menezes-de-Lima, O; Santos, LF; Scheschowitsch, K; Sordi, R | 1 |
| Arita, M; Asano, K; Betsuyaku, T; Fukunaga, K; Miyasho, T; Miyata, J; Obata, T; Seki, H; Takeda, J; Ueda, T | 1 |
| Osuchowski, MF | 1 |
| Capilato, J; Perez, LJ; Pham, MP; Rodriguez, A; Spur, B; Walker, J; Wu, B; Yin, K | 1 |
| Chen, Y; Cheng, Q; Cheng, X; Jiao, J; Kong, L; Ma, R; Miao, S; Wang, Z; Yan, Y; Ye, D | 1 |
| Dichter, E; Kerner, D; Lacorte, G; Rodriguez, A; Spur, B; Walker, J; Yin, K | 1 |
| Altavilla, D; Bitto, A; David, A; Irrera, N; Minutoli, L; Rinaldi, M; Squadrito, F; Venuti, FS | 1 |
12 other study(ies) available for lipoxin a4 and Sepsis
| Article | Year |
|---|---|
[Effect of lipoxin A4 on the expression of Toll-like receptor 4 and TNF receptor-associated factor 6 in the liver of obese rats with sepsis].
Topics: Animals; Humans; Interleukin-6; Lipoxins; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; Sepsis; Signal Transduction; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2018 |
Photobiomodulation modulates the resolution of inflammation during acute lung injury induced by sepsis.
Topics: Acute Lung Injury; Animals; Bone Marrow; Bronchoalveolar Lavage; Cell Movement; Cholinergic Agents; Cytokines; Eicosapentaenoic Acid; Inflammation; Lipopolysaccharides; Lipoxins; Low-Level Light Therapy; Lung; Male; Mice, Inbred BALB C; Muscle Contraction; Muscle, Smooth; Sepsis | 2019 |
[Protective effect of early intervention with lipoxin A4 on septic mice].
Topics: Animals; Early Intervention, Educational; Interleukin-6; Lipoxins; Male; Mice; Sepsis; Tumor Necrosis Factor-alpha | 2019 |
Lipoxin A(4) promotes more complete inflammation resolution in sepsis compared to stable lipoxin A(4) analog.
Topics: Animals; Chromatography, Liquid; Lipoxins; Macrophages; Male; Neutrophils; Phagocytosis; Rats; Rats, Sprague-Dawley; Sepsis; Tandem Mass Spectrometry | 2013 |
Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin.
Topics: Acute-Phase Proteins; Adult; Aged; Aged, 80 and over; Annexin A1; Chemokine CCL20; Female; Humans; Lipocalin-2; Lipocalins; Lipoxins; Male; Middle Aged; Proto-Oncogene Proteins; Sepsis | 2013 |
Dual role of lipoxin A4 in pneumosepsis pathogenesis.
Topics: Animals; Bacterial Load; Cell Movement; Cells, Cultured; Disease Progression; Heptanoic Acids; Interleukin-1beta; Klebsiella Infections; Klebsiella pneumoniae; Lipoxins; Lung; Male; Mice; Oligopeptides; Receptors, Formyl Peptide; Sepsis; Tumor Necrosis Factor-alpha | 2013 |
Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftazidime; Drug Therapy, Combination; Escherichia coli Infections; Inflammation Mediators; Lipoxins; Macrophages; Male; Mice; Mice, Inbred C57BL; Peritonitis; Sepsis | 2014 |
Tender mediation in a ruthless environment: can lipoxins provide lifesaving modifications to fatally deregulated immunoinflammatory responses in sepsis?*.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftazidime; Escherichia coli Infections; Lipoxins; Male; Sepsis | 2014 |
Lipoxin A4 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing inhibition.
Topics: Animals; Antibodies; Bacteremia; Bacterial Proteins; Leukocytes; Lipoxins; Male; Mice; Neutrophils; Phagocytes; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Receptors, IgG; Sepsis; Trans-Activators; Virulence | 2016 |
Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation.
Topics: Animals; Anti-Inflammatory Agents; B-Lymphocytes; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Female; Immunity, Innate; Lipopolysaccharides; Lipoxins; Mice; Mice, Inbred BALB C; Sepsis; STAT5 Transcription Factor | 2016 |
Lipoxin a4 increases survival by decreasing systemic inflammation and bacterial load in sepsis.
Topics: Animals; Bacterial Load; Chemokine CCL2; Inflammation; Interleukin-10; Interleukin-6; Kaplan-Meier Estimate; Lipoxins; Male; NF-kappa B; Phagocytosis; Rats; Rats, Sprague-Dawley; Sepsis | 2011 |
Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis.
Topics: Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Catechin; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprostone; Disease Models, Animal; Drug Combinations; Extracellular Signal-Regulated MAP Kinases; Intracellular Signaling Peptides and Proteins; Leukotriene B4; Lipoxins; Lipoxygenase Inhibitors; Liver; Lung; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Sepsis | 2012 |